IRIS
LAUDICELLA, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.236
NA - Nord America 1.066
AS - Asia 164
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.468
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.062
IE - Irlanda 424
SE - Svezia 372
IT - Italia 282
CN - Cina 105
PL - Polonia 50
DE - Germania 43
IN - India 39
FR - Francia 25
BE - Belgio 15
GB - Regno Unito 8
VN - Vietnam 8
FI - Finlandia 5
IR - Iran 5
NL - Olanda 4
TR - Turchia 4
AT - Austria 3
CA - Canada 2
MX - Messico 2
RO - Romania 2
BR - Brasile 1
CH - Svizzera 1
EU - Europa 1
HK - Hong Kong 1
JP - Giappone 1
MK - Macedonia 1
PH - Filippine 1
UA - Ucraina 1
Totale 2.468
Salva come PNG Salva come JPEG
Città #
Dublin 422
Chandler 413
Nyköping 290
Princeton 74
Messina 72
Ashburn 68
Medford 61
Warsaw 50
Bremen 37
Des Moines 35
Beijing 30
Hyderabad 27
Rome 24
Jacksonville 19
Dearborn 17
Brussels 15
Palermo 14
Jinan 12
Ann Arbor 10
Milan 10
Pune 10
Genoa 9
Cagliari 8
Dong Ket 8
Nanjing 8
Nanchang 7
Seattle 7
Wilmington 7
Redwood City 6
Shenyang 6
Tianjin 6
Santa Domenica 5
Torregrotta 5
Cambridge 4
Florence 4
Fuzhou 4
Helsinki 4
Istanbul 4
San Mateo 4
Waverly Hall 4
Zhengzhou 4
Augusta 3
Changsha 3
Fara Gera d'Adda 3
Haikou 3
Rometta Marea 3
Taiyuan 3
Taizhou 3
Vienna 3
Bari 2
Bologna 2
Catania 2
Chengdu 2
Edinburgh 2
Fairfield 2
Fiumefreddo Di Sicilia 2
Hangzhou 2
Hebei 2
Iasi 2
Lanzhou 2
Lecce 2
Los Angeles 2
Meppel 2
Monmouth Junction 2
New York 2
Padova 2
Pedara 2
Pleasant Hill 2
Pozzo Di Gotto 2
Pozzuoli 2
Quinto Di Treviso 2
Rambouillet 2
Reggio Calabria 2
Santa Teresa Di Riva 2
Vittoria 2
Amsterdam 1
Ancona 1
Angeles City 1
Ardabil 1
Balestrate 1
Belpasso 1
Berlin 1
Brooklyn 1
Castelnuovo Rangone 1
Castelvetrano 1
Codigoro 1
Duncan 1
Guangzhou 1
Hamburg 1
Hanover 1
Hefei 1
Hong Kong 1
Lappeenranta 1
Latina 1
Leawood 1
Limmen 1
London 1
Maple Ridge 1
Monserrato 1
Ningbo 1
Totale 1.925
Salva come PNG Salva come JPEG
Nome #
Artificial intelligence in molecular imaging: from machine to deep learning 112
PRRT Retreatments: Renal Function Evaluation 86
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 77
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 71
Safety, effectiveness and haematological toxicity of 223Radichloride: a single Centre experience 64
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 63
Effectiveness, safety and haematological toxicity of 223Ra-Cl2: a single centre experience 63
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 62
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 61
18F-FDG PET/CT Imaging of Immune Checkpoint Inhibitor-Related "Retroperitoneal Panniculitis" 59
Dual Time-Point FET-PET/CT in Glioma Patients: a Single-Centre Preliminary Experience 59
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 58
Renal Function Evaluation in PRRT Retreatments 57
Clinico-laboratory response and haematological toxicity in patients undergoing therapy with 223RA-dichloride 55
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 54
223RA-dichloride use in patients affected by bone metastases from castration-resistant prostate cancer: single centre experience 52
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 51
[68 Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177 Lu]DOTATOC PRRT: The “Theragnomics” Concept 51
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 49
COVID-19 Surface Persistence: A Recent Data Summary and Its Importance for Medical and Dental Settings 49
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 46
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 44
Prognostic Validity of Dual Tracer PET/CT In The PRRT Enrollment of GEP-NET Patients 44
18F-FACBC in prostate cancer: A systematic review and meta-analysis 44
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 44
Non-invasive cardiac imaging in patients with systemic amyloidosis: a practical approach with emphasis on clinical contribution of bone-seeking radiotracers 42
Is dual tracer PET/CT a prognostic biomarker in the PRRT enrollment of GEP-NET patients? 42
PRRT retreatments: renal function evaluation 42
The utility of dual time-point FET-PET/CT in recurrence assessment of glioma patients 41
Artifcial intelligence applications in SSTR targeted PET/CT images: prediction of response assessment in GEP-NETs undergoing PRRT with [177Lu]DOTATOC 41
Correction to: 18F-FMISO PET imaging: insights over MRI in patients with glioma (Clinical and Translational Imaging, (2020), 8, 1, (3-10), 10.1007/s40336-019-00353-0) 39
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 38
Prognostic insights of molecular imaging in cardiac sarcoidosis 37
Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination 37
Peptide Receptor Radionuclide Therapy of Pulmonary Neuroendocrine Neoplasms: a Single-Centre Experience 36
Sars-cov-2 persistence: data summary up to q2 2020 35
18F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma 34
Imaging gastrin-releasing peptide receptors (GRPRs) in prostate cancer 32
[18F] Fluorothymidine Positron Emission Tomography Imaging in Primary Brain Tumours: A Systematic Review 31
The additional value of 18F-FDG PET and MRI in patients with glioma: A review of the literature from 2015 to 2020 31
Artificial intelligence applications in 68Ga-DOTA PETICT images: Prediction of response assessment in GEP-NETs undergoing PRRT with 177Lu-DOTATOC 31
Artificial neural networks in cardiovascular diseases and its potential for clinical application in molecular imaging 29
[177Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective 29
Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas 29
Artificial intelligence in molecular imaging: from machine to deep learning 29
Combined use of peptide receptor radionuclide therapy and metronomic chemotherapy in neuroendocrine tumors: a possible choice driven by nuclear medicine molecular imaging 29
Artificial Intelligence Applications on Restaging [18F]FDG PET/CT in Metastatic Colorectal Cancer: A Preliminary Report of Morpho-Functional Radiomics Classification for Prediction of Disease Outcome 27
Malignant cutaneous melanoma: Updates in PET imaging 26
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 26
Radiomics Analysis of Brain [18 F]FDG PET/CT to Predict Alzheimer’s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis 25
PET/MR in neuro-oncology: is it ready for prime-time? 24
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 23
null 23
The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence Also in Comparison with MRI 22
Prostate Cancer Biochemical Recurrence Resulted Negative on [68Ga]Ga-PSMA-11 but Positive on [18F]Fluoromethylcholine PET/CT 20
Emerging applications of imaging in glioma: focus on PET/MRI and radiomics 20
Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients 20
Molecular imaging of pancreatic neoplasms 17
null 16
Preliminary Findings of the Role of FAPi in Prostate Cancer Theranostics 15
Monitoring of cardiac transthyretin amyloid load by [Tc-99m]DPD scintigraphy: is it the end of the semi-quantitative evaluation? 13
Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose 12
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 11
The role of PET radiomic features in prostate cancer: a systematic review 10
Response prediction to PRRT in progressing and metastatic GEP-NET undergoing restaging 68Ga-DOTA PETICT: A preliminary multicenter radiomics study 10
The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients 9
PET-based artificial intelligence applications in cardiac nuclear medicine 7
The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers 5
null 3
PET Imaging in Gliomas: Clinical Principles and Synergies with MRI 3
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study 1
Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics 1
Totale 2.598
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.721
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 0 9 1
2019/2020111 1 0 0 5 7 15 9 8 3 23 11 29
2020/2021259 22 5 60 6 29 13 12 14 43 27 17 11
2021/2022464 6 30 4 22 31 13 27 34 6 54 35 202
2022/20231.397 119 196 70 107 91 141 17 91 487 16 38 24
2023/2024333 42 40 24 43 44 50 13 35 9 32 1 0
Totale 2.598